Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis

Pancreatic cancer, mostly pancreatic ductal adenocarcinoma (PDAC), is one of the most lethal cancer types, with an estimated 44,330 death in 2018 in the US alone. While targeted therapies and immune checkpoint inhibitors have significantly improved treatment options for patients with lung cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Dongsheng, Lin, Hai, Zhang, Xiaoli, Fan, Qipeng, Chen, Shaoxiong, Shahda, Safi, Liu, Yunlong, Sun, Jie, Xie, Jingwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266431/
https://www.ncbi.nlm.nih.gov/pubmed/30373214
http://dx.doi.org/10.3390/cancers10110403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266431/
https://www.ncbi.nlm.nih.gov/pubmed/30373214
http://dx.doi.org/10.3390/cancers10110403

Ejemplares similares